The healthcare company's dividend has soared in recent years.
These companies did well for shareholders over the last 10 years and have the potential to keep the growth going.
The wealth created by this medical devices company for its investors over the past decade far exceeds what the Dow Jones generated.
This medical device maker has crushed the S&P 500 index in the past 10 years.
Does LeMaitre Vascular (LMAT) have what it takes to be a top stock pick for momentum investors? Let's find out.
LeMaitre announced first-quarter earnings and guidance numbers.
LeMaitre (LMAT) delivered earnings and revenue surprises of 8% and 7.63%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?